Preparation of floxuridine diacetate solid lipid nanoparticles;

Concentration Determination of Floxuridine in Serum and Organs of Mice by RP-HPLC;

Pharmacokinetics of floxuridine in patients with trophoblastic Tumors;

Factors affecting the conversion rate of 5-fluorouridine;

An efficient method column chromatography was used to separate the biotransformed products-5-fluorouridine.

Study on the efficacy and safety of doxifluridine in treatment of advanced gastric cancer and colorectal cancer;

Determination of relatesd substances of Doxifluridine by HPLC;

Clinical effective analysis of doxifluridine combined with late course accelerated hyperfractionated radiotherapy for esophageal carcinoma;

The Influences of Preoperative Oral 5′-DFUR Administration on PD-ECGF in Gastric Carcinoma;

Objective To compare the short-term efficacy of TF (Taxol+5-fluorouracil) and OLD (Oxaliplatin+5′-DFUR+LV) in the treatment of advanced gastric carcinoma.